Releases

News

Releases

23. September, 2022

Successful outcome of pharmacokinetic trial in children of lead candidate

Cessatech A/S announces positive topline outcome of its Phase 2 pharmacokinetics trial with CT001...

Read more

Releases

5. September, 2022

First patient dosed in pivotal trial of lead product candidate

First patient has been dosed in pivotal trial of lead candidate CT001 The pivotal...

Read more

Releases

19. August, 2022

Second quarter report Q2-2022

Cessatech A/S today releases its results for the period 1 April – 30 June...

Read more

Releases

30. June, 2022

Regulatory Green Light for trial 0205, the pivotal trial for CT001 – first patient expected shortly

Cessatech A/S announces that the pivotal trial 0205 has obtained regulatory approval and thereby...

Read more

Releases

16. May, 2022

Cessatech reports last patient dosed in pharmacokinetic trial in children of lead candidate

Clinical trial 0206 will investigate the pharmacokinetics of CT001 in children aged 1-17 undergoing...

Read more

Releases

19. April, 2022

First quarter report Q1-2022

Cessatech A/S today releases its results for the period 1 January – 31 March...

Read more

Releases

8. March, 2022

Successful outcome from trial 0204

Cessatech reports successful outcome of bioavailability trial 0204 Topline results of clinical trial 0204...

Read more

Releases

3. March, 2022

Annual report 2021 published

Cessatech A/S publishes its annual report for the fiscal year 2021. “We managed to...

Read more

Releases

6. January, 2022

Changes to the Board of Directors – welcome to Rachel

Cessatech has appointed Rachel Curtis Gravesen as Observer to the Board of Directors with...

Read more

Releases

22. December, 2021

Cessatech successfully raises DKK 24.3 million through warrant exercise

During the period 25 November – 16 December 2021, holders of TO 1 have...

Read more

Releases

25. November, 2021

Exercise warrants of series TO1 before 14 Dec

In connection with the Company’s IPO in November/December 2020, Cessatech issued units (shares and...

Read more

Releases

2. November, 2021

First US patent covering CT001

The United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11.160.799...

Read more

Want to see all releases?

To see all releases including those not listed here, go to our filings and reports.

Stay up to date!

Subscribe and get notified on Cessatech's latest news.